Blog  /  Insights

The common cold could build immunity toward covid

A person wearing a patterned mask and backpack sits on a ledge beside a bustling city street, conscious of the ongoing battle against COVID. Cars zip by, each carrying passengers mindful of their health and immunity in the urban landscape.

In response to new research suggesting some people may already be primed to fight the coronavirus, 77% of global Sermo physicians (in a poll of about 600), believe it is possible that something as simple as a common cold could help build a person’s immunity toward the coronavirus. In addition, 69% of physicians said they have personally noticed that some people appear to have an immunity to the coronavirus, despite never having been exposed. 

Scientists believe harnessing the biological processes at play here, could aid the search for a new vaccine—and 83% of Sermo physicians agree and are encouraged by this research. These findings are also alleviating the fear that people can be reinfected by Covid-19, say 69% of the doctors. 

Here’s more on what Sermo physicians are saying on this topic:

Screenshot of a comment dated June 17, 2020, from General Practice, discussing how individual immune systems impact immunity against coronavirus variants, similar to how the body handles the common cold.
As a General Practice doctor, I've observed that while vaccination boosts our initial immune response against COVID-19, waning immunity over time can lead to potential reinfections, much like with the common cold.
As a cosmetic surgeon, it's crucial to understand how vaccines enhance our immunity and protect us against diseases. Whether it's the common cold or Covid, maintaining robust virus resistance is key to overall health and well-being. Stay informed and prioritize your immune system! #HealthMatters.
Recent studies highlight a correlation between the MMR vaccine and less severe disease outcomes, noting reduced cases and deaths in areas with recent MMR vaccine programs. This enhanced immunity may also offer insights into broader viral responses, including those related to COVID-19.